BRAF and colorectal cancer: These pathways also begin to resemble pathogenesis of solid tumours where mutant BRAF in progenitor cells is insufficient to induce full-blown malignancy [16], and additional driver events may well also derive from inflammation-associated interactions with precursor cells, such as those implicated in colorectal cancer [48].